economy
March 12, 2026
The conditions are just right for this dividend-paying pharma stock as it mounts a comeback
This darling of the Covid era has given back considerable gains in recent years, but it could be on the verge of a turnaround.
TL;DR
- Pfizer stock is exhibiting technical indicators suggesting a potential reversal and comeback.
- The stock has broken its downtrend, shows a consistent series of higher lows, and is trading above its 50-week moving average.
- Daily chart analysis reveals support at the rising 50-day moving average and the formation of an ascending triangle with a $30.50 upside target.
- A bullish golden cross has formed, and the stock is expected to rally towards its 200-week moving average at $32 if it breaks above $27.50.
- The stock offers a 6.4% dividend yield, and the large pharma sector is considered a safe haven during market volatility.
- If the price falls below $25, investors may consider stepping away, but the current setup offers a good risk/reward scenario.
Continue reading the original article